RHJA
MDGL icon

Rice Hall James & Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History

Rice Hall James & Associates’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-843
Closed -$51K – 311
2015
Q3 		$51K Sell
843
-38
-4% -$2.74K ﹤0.01% 299
2015
Q2 		$69K Sell
881
-92
-9% -$7.72K ﹤0.01% 308
2015
Q1 		$66K Buy
973
+275
+39% +$23.6K ﹤0.01% 313
2014
Q4 		$65K Sell
698
-232
-25% -$24K ﹤0.01% 303
2014
Q3 		$98K Buy
930
+11
+1% +$1.53K 0.01% 295
2014
Q2 		$132K Buy
919
+13
+1% +$1.9K 0.01% 299
2014
Q1 		$137K Buy
906
+37
+4% +$7.29K 0.01% 297
2013
Q4 		$159K Buy
+869
New +$159K 0.01% 296

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return